Search Results - "Iu S Shapovalova"

Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study by E O Ignatova, O N Burdaeva, M V Kopp, B N Kotiv, D P Udovitsa, D L Stroiakovskii, S M Alekseev, L P Sheveleva, A V Khorinko, Iu S Shapovalova, V M Moiseenko, R A Ivanov

“…Objective. Within the multi-center double-blind randomized clinical study, investigate the bioequivalence (immediate efficacy, safety and pharmacokinetics) of…”
Get full text

Clinical signs of endothelial disorders in patients with severe sepsis by Plotkin, L L, Bespalov, A M, Smirnov, D M, Timchenko, N N, Shapovalova, Iu S, Konradi, A B

“…A clinical-experimental study was carried out. The objective was to find some regularities in endothelial disorder progression in patients with severe sepsis…”
Get more information